AKT1 and non-small cell lung carcinoma: These results implied that ENO1 is an upstream signal factor modulating the FAK/PI3K/AKT pathway in NSCLC, and ENO1 regulates FAK/PI3K/AKT pathway to promote cell glycolysis, proliferation, migration, and invasion.